Alison D. Silva
President at JUPITER NEUROSCIENCES, INC.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Aoife Brennan | M | 48 |
Synlogic Operating Co., Inc.
 Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Synlogic Operating Co., Inc. operates as a biopharmaceutical company. The firm's pipeline focuses on rare diseases, the company is leveraging the broad potential of its synthetic biotics platform for novel drug development in major disease areas through partnerships with pharmaceutical and biotechnology companies. It also engages in development of synthetic biotics-based treatment for inflammatory bowel disease. The company was founded by James J. Collins and Timothy K. Lu in 2014 and is headquartered in Cambridge, MA. | 8 years |
| Christer Rosén | M | 72 | 9 years | |
| Marshall Hayward | M | 69 | 9 years | |
| John Matthew Bond | M | 63 | 6 years | |
| John C. Drake | M | - | 17 years | |
| Nick Leschly | M | 51 |
Synlogic Operating Co., Inc.
Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Synlogic Operating Co., Inc. operates as a biopharmaceutical company. The firm's pipeline focuses on rare diseases, the company is leveraging the broad potential of its synthetic biotics platform for novel drug development in major disease areas through partnerships with pharmaceutical and biotechnology companies. It also engages in development of synthetic biotics-based treatment for inflammatory bowel disease. The company was founded by James J. Collins and Timothy K. Lu in 2014 and is headquartered in Cambridge, MA. | 8 years |
| Nicholas Hemmerly | M | 42 | 3 years | |
| John Ditton | M | 60 | 3 years | |
| Holger Weis | M | 61 | 3 years | |
| Julie Kampf | F | 62 | 3 years | |
| David Sanderson | M | - | 11 years | |
| Alexander Rosén | M | 33 | 9 years | |
| Allison W. Brady | F | 53 | 3 years | |
| Richard Theodore Ho | M | 61 | 7 years | |
| Debi Sanderson | F | - | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jose-Carlos Gutiérrez-Ramos | M | 61 |
Synlogic Operating Co., Inc.
Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Synlogic Operating Co., Inc. operates as a biopharmaceutical company. The firm's pipeline focuses on rare diseases, the company is leveraging the broad potential of its synthetic biotics platform for novel drug development in major disease areas through partnerships with pharmaceutical and biotechnology companies. It also engages in development of synthetic biotics-based treatment for inflammatory bowel disease. The company was founded by James J. Collins and Timothy K. Lu in 2014 and is headquartered in Cambridge, MA. | 3 years |
| Wayne R. Danter | M | - | 11 years | |
| J. Michael French | M | 63 | 8 years | |
| Peter García | M | 62 | 2 years | |
| Jacob Uittenbogaard | M | - | 5 years | |
| Bharatt Chowrira | M | 59 |
Synlogic Operating Co., Inc.
Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Synlogic Operating Co., Inc. operates as a biopharmaceutical company. The firm's pipeline focuses on rare diseases, the company is leveraging the broad potential of its synthetic biotics platform for novel drug development in major disease areas through partnerships with pharmaceutical and biotechnology companies. It also engages in development of synthetic biotics-based treatment for inflammatory bowel disease. The company was founded by James J. Collins and Timothy K. Lu in 2014 and is headquartered in Cambridge, MA. | 2 years |
| Dana Eschenburg Perez | F | 47 | 2 years | |
| Chau Khuong | M | 48 | 5 years | |
| Michael Staton | M | - |
Clark University
| 5 years |
| Douglas S. Alexander | M | 66 | 10 years | |
| Gregory Sessler | M | 71 | 4 years | |
| Eugene Francis Kelly | M | - | 12 years | |
| Marco Angelo C. Alcantara | M | - |
Clark University
| 5 years |
| John Yoo | M | - | - | |
| James Karis | M | 76 | 3 years | |
| Rahul Doshi | M | - |
Clark University
| 4 years |
| J. Chuck LaPosta | M | - |
Clark University
| 2 years |
| Elif Lévesque | F | - |
Clark University
| 2 years |
| Chris Harvey | M | - |
Clark University
| 4 years |
| Barry A. Polisky | M | 78 | 2 years | |
| Tori J. Fogg | F | - |
Clark University
| 4 years |
| David Sinclair | M | - | 2 years | |
| Victor Hugo | M | 55 | 3 years | |
| Mia Davis | F | - |
Clark University
| 6 years |
| Braz Ilya | M | - |
Clark University
| 4 years |
| Tori J. Stewart | F | - |
Clark University
| 4 years |
| Gunjan K. Banati | F | - |
Clark University
| 4 years |
| Shannon Joyce | F | - |
Clark University
| 4 years |
| Andrew Littlehale | M | - |
Synlogic Operating Co., Inc.
Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Synlogic Operating Co., Inc. operates as a biopharmaceutical company. The firm's pipeline focuses on rare diseases, the company is leveraging the broad potential of its synthetic biotics platform for novel drug development in major disease areas through partnerships with pharmaceutical and biotechnology companies. It also engages in development of synthetic biotics-based treatment for inflammatory bowel disease. The company was founded by James J. Collins and Timothy K. Lu in 2014 and is headquartered in Cambridge, MA. | - |
| Rachel Heller Scott | F | - |
Clark University
| 4 years |
| Yu Gang Zhang | M | 51 |
Clark University
| 2 years |
| Michael Taylor | M | 69 | 2 years | |
| Christine D. Franquin | F | - |
Clark University
| 2 years |
| Hassan Ibrahim Ahmed | M | - |
Clark University
| 4 years |
| June D. Ameen | F | 67 | - | |
| Michael Rose | M | - |
Clark University
| 4 years |
| Sahul N. Sharma | M | - |
Clark University
| 4 years |
| James Parker Loring | M | - |
Clark University
| 2 years |
| Mark F. Boshar | M | - |
Synlogic Operating Co., Inc.
Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Synlogic Operating Co., Inc. operates as a biopharmaceutical company. The firm's pipeline focuses on rare diseases, the company is leveraging the broad potential of its synthetic biotics platform for novel drug development in major disease areas through partnerships with pharmaceutical and biotechnology companies. It also engages in development of synthetic biotics-based treatment for inflammatory bowel disease. The company was founded by James J. Collins and Timothy K. Lu in 2014 and is headquartered in Cambridge, MA. | - |
| Shawn R. Fields | M | - |
Clark University
| 1 years |
| Dean A. Falb | M | 63 | 5 years | |
| Paul S. Miller | M | 65 |
Synlogic Operating Co., Inc.
Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Synlogic Operating Co., Inc. operates as a biopharmaceutical company. The firm's pipeline focuses on rare diseases, the company is leveraging the broad potential of its synthetic biotics platform for novel drug development in major disease areas through partnerships with pharmaceutical and biotechnology companies. It also engages in development of synthetic biotics-based treatment for inflammatory bowel disease. The company was founded by James J. Collins and Timothy K. Lu in 2014 and is headquartered in Cambridge, MA. | - |
| Fadi Swidan | M | - |
Clark University
| 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 58 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Alison D. Silva
- Personal Network
